– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –Vancouver, B.C., …
Daily Archives
November 8, 2025
-
-
Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy
by Asia InsiderAtacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met …